A389030 logo

GENINUS Inc. Stock Price

KOSDAQ:A389030 Community·₩180.9b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

A389030 Share Price Performance

₩0
-1205.00 (-100.00%)
₩0
-1205.00 (-100.00%)
Price ₩0

A389030 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Adequate balance sheet and overvalued.

1 Risk
1 Reward

GENINUS Inc. Key Details

₩10.5b

Revenue

₩10.4b

Cost of Revenue

₩110.4m

Gross Profit

₩17.5b

Other Expenses

-₩17.4b

Earnings

Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
n/a
-519.60
1.05%
-165.72%
87.7%
View Full Analysis

About A389030

Founded
2018
Employees
74
CEO
Woongyang Park
WebsiteView website
kr-geninus.com

GENINUS Inc., a bioinformation analysis company, engages in the research and development, manufacture, and sale of genome analysis solutions in South Korea, the United States, and Asia. It offers tarhet and biomarker discovery; AI digital pathology; single cell analysis; and spatial and in-situ transcriptomics services; and SPACEINSIGHT, a cutting-edge cloud based integrated analysis platform. It serves hospitals, pharmaceutical companies, and researchers. The company was founded in 2018 and is headquartered in Seoul, South Korea.

Recent A389030 News & Updates

Recent updates

No updates